As a 2025 comprehensive review by Jzwiak and colleagues in Pharmaceuticals (Basel) documents, BPC-157 was isolated from human gastric juice and has been studied in preclinical models since the early 1990s by a research group at the University of Zagreb
References Frontiers in Endocrinology (2021) Progress on the Function and Application of Thymosin 4 Annals of the New York Academy of Sciences Thymosin 4: roles in development, repair, and engineering of the cardiovascular system Frontiers in Pharmacology (2022) Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 HSS Journal (2025) Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review Current Pharmaceutical Design (2018) Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract Journal of Orthopaedic Surgery and Research (2019) BPC 157 and its effects on tendon healing CDC (2024) Vaccine Administration: Subcutaneous (SUBCUT) Injection NCBI Bookshelf (2023) Administration of Parenteral Medications Nursing Skills CDC (NCHS) Laboratory Procedure Manual: C-Peptide in Serum (storage guidelines) Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
Weinheim, Baden-Wurttemberg, Ger
Key Research Areas USP-grade sterile water 0.9% benzyl alcohol preservative 30ML multi-use vial Ideal for peptide reconstitution Extended shelf life after opening Quality Assurance All Bacteriostatic Water batches are third-party tested with Certificates of Analysis available for verification
Research Applications From Tendon Models to Gut Barrier Research BPC-157 is investigated across an unusually broad range of tissue-repair and protective-research models, reflecting both the breadth of its documented activity profile and its administrative flexibility in pre-clinical designs
